Antibiotic Module

Embed Size (px)

Citation preview

  • 8/3/2019 Antibiotic Module

    1/49

  • 8/3/2019 Antibiotic Module

    2/49

    Objectives

    1. Enumerate Principles of antimicrobial

    therapy

    2. Verify Choice of the antimicrobial agents

    3. State Misuse of antibiotics

    4. Mention Causes of failure of antimicrobial

    therapy5. Classify antimicrobial drugs

  • 8/3/2019 Antibiotic Module

    3/49

    Principles of antimicrobial

    therapy

  • 8/3/2019 Antibiotic Module

    4/49

  • 8/3/2019 Antibiotic Module

    5/49

    What are the principles of antimicrobial therapy ?

    Appropriate indication

    Appropriate dosage

    Suitable length of treatment period

    When to start treatment

    Target of therapy (prophylaxis or treatment).

    Good knowledge of the drug's pharmacokinetics and

    potential risk.

    Combination only under certain conditions and rightchoice of combination.

    5

  • 8/3/2019 Antibiotic Module

    6/49

    When do you start the treatment?

    Ideally

    when the organism is identified and its drug

    susceptibility established

    However,acutely ill patients usually require

    immediate treatment

    Empiric therapy :Therapy is initiated afterspecimens for laboratory analysis have beenobtained but before the results of the culture are

    available.

  • 8/3/2019 Antibiotic Module

    7/49

    What are the purposes for use of

    antibiotics ? (Aim of therapy )

    Prophylaxis A Medical:

    - Exposure to virulent pathogen (HIV, N. meningitis)

    - Immunocompromised Bsurgical

    - To prevent wound infections after surgical procedures.

    To prevent Endocarditis inpatients with valvular heart disease undergoing

    dental or other surgeries producing bacteremia. Empiric Therapy (usually up to 72 hours)

    Definitive Therapy

    7

  • 8/3/2019 Antibiotic Module

    8/49

    Combinations Of Antimicrobial Drugs

    8

  • 8/3/2019 Antibiotic Module

    9/49

    Combinations Of Antimicrobial Drugs

    Indication:1. Empiric therapy of severe infection in which cause is

    unknown(unknown etiology)

    2. In mixed infections(polymicrobial infections),e.g. intra-abdominalinfections.

    3. To delay emergence of resistant strains

    4. To enhance antimicrobial activity , i.e. achieve an effect notobtained by either alone(e.g. combinations of penicillin and

    aminoglycoside antibiotics are effective against enterococci,whereas neither agent alone is bactericidal againstenterococci).

    5. To reduce the incidence and intensity of adverse reactions.

    9

  • 8/3/2019 Antibiotic Module

    10/49

    Antibiotic combination therapy:

    Synergistic Effect: when the effects of a combination of antibiotics

    is greater than the sum of the effects of the individual antibiotics.When two bactericidal antibiotics are used in combination (e.g.

    penicillin + streptomycin)

    Additive Effect:When two bacteriostatic agents with the same mechanisms

    of action are used.

    Antagonism: occurs when one antibiotic, interferes with the effects

    of another antibiotic. Usually bacteriostatic antibiotics are

    antagonistic to bactericidal agents.

    (e.g. Chloramphenicol + penicillin)

  • 8/3/2019 Antibiotic Module

    11/49

    Choice of the antimicrobial

    agents

  • 8/3/2019 Antibiotic Module

    12/49

    Choice of The Antimicrobial Agent

    A- Factors related to drug:

    Antibiotic spectrum and activity.

    The minimal inhibitory concentration (MIC)

    compared to concentration achieved at site of

    infection

    known risk of the antibiotic, like nephrotoxicity

    with aminoglycosides Possibility of developing resistance.

    Drug's phamacokinetic parameters: absorption,

    distribution and clearance.

  • 8/3/2019 Antibiotic Module

    13/49

    Spectrum of Activity

    Refers to the range of microorganisms that anantimicrobial agent can kill or inhibit

    Broad spectrum

    affect a wide range of bacteria used particularly in the cases of rapid onset life-

    threatening infections, when there is no time to culture

    the causative agent

    can disrupt the normal flora of the body leading tosuperinfection.

    Narrow spectrum

    Affect a limited range of bacteria

    requires the identification of the pathogen

  • 8/3/2019 Antibiotic Module

    14/49

    Antibiotic activity

    Bacteriostatic - arrest the growth and replication of bacteria

    at serum levels achievable in the patient .

    They reversibly inhibit the growth of bacteria .They limit the

    spread of infection while the body's immune system attacks,

    immobilizes, and eliminates the pathogens.

    If the drug is removed before the immune system has

    scavenged the organisms, enough viable organisms may

    remain to begin a 2nd cycle of infection. Therefore must be

    given for enough duration of time.

    If possible, bactericidal antibiotics should be used to treat

    infections of the endocardium or the meninges. Host

    defenses are relatively ineffective at these sites and the

    dangers imposed by such infections require prompteradication of the organisms.

  • 8/3/2019 Antibiotic Module

    15/49

    Bactericidal - kill bacteria at drug serum levels

    achievable in the patient. - often drugs of

    choice in seriously ill patients.

  • 8/3/2019 Antibiotic Module

    16/49

    Concentration of antibiotic

    Minimum inhibitory concentration (MIC):

    The lowest concentration of AB that inhibits bacterial

    growth after overnight incubation.

    Minimum bactericidal concentration (MBC):

    The lowest concentration of AB that results in a 99.9

    percent decline in colony count after overnight incubation.

  • 8/3/2019 Antibiotic Module

    17/49

    Drug resistance

    Bacteria are said to be resistant to an

    antibiotic if their growth is not halted by the

    maximal level of that antibiotic that can be

    tolerated by the host

  • 8/3/2019 Antibiotic Module

    18/49

    Choice of The Antimicrobial Agent

    B- Factors related to host1. Host's defense mechanisms

    2. Host's clinical conditions

    3. Local factors

    4. Age

    5. Genetic factors

    6. Pregnancy and lactation

    7. Drug allergy

  • 8/3/2019 Antibiotic Module

    19/49

    1. Host's defense mechanisms

    Immune system:

    The host defense system must eliminate invading

    organisms.

    Alcoholism, diabetes, immunodeficiency virus,

    malnutrition, advanced age affect a patient'simmunocompetency.

    if host defense are impaired in these individuals:

    A bactericidalATB must be used : Higher-than-usual doses of

    bactericidal ATB or longer courses of treatment .

  • 8/3/2019 Antibiotic Module

    20/49

    2. Host's clinical conditions

    Renal dysfunction:

    Poor kidney function (10 % or less of normal) - accumulation of ATB

    (eliminated by kidney) - serious adverse effects adjust the dose of

    ATB eliminated by the kidney and avoid nephrotoxic ABTs.

    Hepatic dysfunction:

    ATB concentrated or eliminated by the liver (e.g., erythromycin and

    tetracycline) are contraindicated in liver disease.

  • 8/3/2019 Antibiotic Module

    21/49

    3-Local Factors

    Access of antibiotic to sites of infection e.g.if the infection in the CSF the drug must pass

    the blood brain barrier

    Penetration of antibiotic into infected areassuch abscess is impaired because vascular

    supply is reduced &antimicrobial activity may

    be significantly reduced in pus. Presence of the foreign bodies reduces the

    effectiveness of antibiotic.

  • 8/3/2019 Antibiotic Module

    22/49

    4-Age

    Elderly patients - particularly vulnerable toaccumulation of drugs eliminated by the kidneys. The

    number of functioning nephrons decreases with age.

    Young children -Renal or hepatic elimination - oftenpoorly developed in newborns

    Also newborns are particularly vulnerable to certain

    antibiotics.

  • 8/3/2019 Antibiotic Module

    23/49

    5- Genetic Factors

    A number of drugs (e.g. sulfonamides,

    chloramphenicol) may produce acute

    hemolysis in patient with glucose 6-phosphate dehydrogenase deficiency

  • 8/3/2019 Antibiotic Module

    24/49

    6- Pregnancy

    Pregnancy may impose an increased risk of

    reaction to antibiotic for both mother & fetus

    Hearing loss in child with administration of

    streptomycin to the mother during pregnancy

    Tetracycline can affect bones & teeth of fetus .

  • 8/3/2019 Antibiotic Module

    25/49

    7- Drug allergy

    -lactum ABTs e may provoke allergic reaction

    Sulfonamides and erythromycin have been

    associated with hypersentitivity reaction

  • 8/3/2019 Antibiotic Module

    26/49

    What are the causes of Misuse of

    antibiotics?

    Treatment of untreatable infection

    Treatment of fever of undetermined origin

    Improper dose

    Reliance on chemotherapy with omission of

    surgical drainage of purulent exudates or

    necrotic tissue

    Lack of adequate bacteriological information

    26

  • 8/3/2019 Antibiotic Module

    27/49

    Causes of Failure of

    Antimicrobial Treatment

  • 8/3/2019 Antibiotic Module

    28/49

    Causes of Failure of Antimicrobial

    Treatment

    Incorrect indication

    Ineffective antibiotic Inapproapirate dosage

    Inadequate duration

    Development of resistance

    Change of causative pathogens

  • 8/3/2019 Antibiotic Module

    29/49

    Classify Antibiotics

    Classification of Antibiotics according:

    Chemical Structure

    Spectrum of Activity& effects Mechanism of Action

    29

  • 8/3/2019 Antibiotic Module

    30/49

    Classify Antibiotics

    Spectrum of Antibiotic activity

    Narrow spectrum Antibiotic

    Broad spectrum Antibiotic

    Effects of Antibiotics

    Bacteriostatic

    Bacteriocidal

  • 8/3/2019 Antibiotic Module

    31/49

    Classification of some antibacterial agents by their sites of action

    THFA = tetrahydrofolic acid; PABA = p-aminobenzoic acid

    CELL WALLCELL MEMBRANE

    DNA

    THFA

    PABARibosomes mRNA

    Inhibitors of cellmembranefunction

    IsoniazidAmphotericin B

    Inhibitors ofnucleic acidfunction orsynthesis

    FluoroquinolonesRifampin

    Inhibitors ofmetabolism

    SulfonamidesTrimethoprim

    Inhibitors of cellwall synthesis

    b-LactamsVancomycin

    Inhibitors ofprotein synthesis

    TetracyclinesAminoglycosidesMacrolidesClindamycinChloramphenicol

  • 8/3/2019 Antibiotic Module

    32/49

    Cell wall synthesis inhibitors

    Summary of anti microbial agents affecting cell wall

  • 8/3/2019 Antibiotic Module

    33/49

    Summary of antimicrobial agents affecting cell wallsynthesis

    INHIBITORS OF CELLWALL SYNTHESIS b-LACTAMASE

    INHIBITORS

    b-LACTAMANTIBIOTIC

    OTHERANTIBIOTIC

    PENICILLINS CEPHALOSPORINS CARBAPENEMS MONOBACTAMS

    1st GENERATION 2nd GENERATION 3rd GENERATION 4th GENERATION

    Clavulanic acidSulbactamTazobactam

    BacitracinVancomycin

    Imipenem/cilastatinMeropenem*Ertapenem

    Aztreonam

    Cefepime

    AmoxicillinAmpicillinCloxacillinDicloxacillinIndanyl carbenicillinMethicillin

    NafcillinOxacillinPenicillin GPenicillin VPiperacillinTicarcillin

    CefadroxilCefazolinCephalexinCephalothin

    CefaclorCefamandoleCefprozilCefuroximeCefotetanCefoxitin

    CefdinirCefiximeCefoperazoneCefotaximeCeftazidimeCeftibutenCeftizoximeCeftriaxone

  • 8/3/2019 Antibiotic Module

    34/49

    The Beta-lactams

    Beta-lactams are a broad class of antibioticsthat have in common a four membered beta-

    lactam ring structure. They include:

    1. Penicillins,

    2. Cephalosporins,

    3. Carbapenems,

    4. Monobactam

    34

  • 8/3/2019 Antibiotic Module

    35/49

    b-lactam Antibiotics

    35

    Monobactams

    All of the drugs in this group containa -lactam ring in their structure

    Penicillins

    NO

    S

    Carbapenems

    NO

    NO

    NO

    S

    Cephalosporins

    Share similar features of chemistry,

    mechanism of action Cross reactivity

    Bacteria might develop resistance to

    -lactam antibiotics by synthesizingbeta lactamase, an enzyme that

    attacks the-lactam ring.

  • 8/3/2019 Antibiotic Module

    36/49

    What is the mechanism of action of

    penicillin ?

    Penicillins enter the bacteria via the cell wall

    Inside the cell, they bind to penicillin-binding protein

    Once bound, normal cell wall synthesis is disrupted

    Result: bacteria cells die from cell lyses

    Penicillins do not kill other cells in the body

    36

  • 8/3/2019 Antibiotic Module

    37/49

    Penicillin Groups1. Penicillin G ( -Lactamase sensitive)

    2. Depot preparations: (long actin preparations) ( -Lactamase sensitive)

    3. Acid resistant penicillins (penicillin V) ( -Lactamase

    sensitive).

    4. -Lactamase -resistant penicillins (anti-

    staphylococcal penicillins). 1,2 ,3 & 4 are narrow

    spectrum

    5. Broad spectrum penicillins ( -Lactamase sensitive)6. Antipseudomonal penicillins (extended spectrum

    penicillin) ( -Lactamase sensitive)

  • 8/3/2019 Antibiotic Module

    38/49

    1- Penicillins G

    Pharmacokinetics Penicillin G is rapidly hydrolyzed by gastric acidity, so it is

    not given orally but only parenterally

    There is poor penetration into CSF, unless inflammation is

    present. Active renal tubular secretion results in a short half-life.

    counteracted by

    - Giving high doses

    - Simultaneous administration of probencid

    - Using the depot preparations

    38

  • 8/3/2019 Antibiotic Module

    39/49

    What are the disadvantages of

    Penicillins G?

    1. Short duration of action.

    2. Instability in acidic medium.

    3. Destroyed by b-Lactamase enzymes.

    4. Possess a narrow spectrum of activity(active

    against some gram +ve and gramve ) .

  • 8/3/2019 Antibiotic Module

    40/49

    2- Depot preparations:(long actin preparations)

    penicillin Gprocaine(used every 18-24 hours)

    penicillin G benzathine (duration ofantimicrobial activity in the plasma is up to

    one month) Such agents release penicillin G slowly from

    the area in which they are injected andproduce relatively low but persistentconcentrations of antibiotic in the blood.

  • 8/3/2019 Antibiotic Module

    41/49

    3-Acid-stable Penicillins- penicillin V

    - Theoralform of penicillins

    - Indicated only in minor infections because of:

    1. Poor bioavailability.

    2. Frequent dosing 4-6 times per day.3. Narrow spectrum of activity.

    4. -Lactamase sensitivity.

    5. Cant be used for treatment of bacteraemia

    because of high lethal dose needed.

    41

    4 Lactamase resistant penicillins

  • 8/3/2019 Antibiotic Module

    42/49

    4- -Lactamase -resistant penicillins

    (Anti-staphylococcal penicillins)

    Nafcillin,(I.V)

    Dicloxacillin (oral)

    These antibiotics are most useful against infections

    caused by -Lactamase -producing staphylococci.

    Nafcillin is excreted in bile.

    42

    d i illi

  • 8/3/2019 Antibiotic Module

    43/49

    5- Broad spectrum penicillins(Aminopenicillins) (ampicillin, amoxicillin)

    - Developed to increase activity against gram-negative aerobes, including some strains of E.coli, Klebsiella, and Haemophilus. But not activeagainst Pseudomonas.

    - Broad-spectrum penicillin but beta lactamasesensitive.

    - Amoxicillin is often combined with clavulanate(b

    lactamae inhibitor), and this combination can be

    used for beta-lactamases producing organisms.

    6 Antipseudomonal penicilins

  • 8/3/2019 Antibiotic Module

    44/49

    6- Antipseudomonal penicilins

    Ticarcillin

    These agents have similar spectrums of activity as the

    aminopenicillins but with additional activity against

    several gram negative organisms including many

    strains of Pseudomonas aeruginosa. Like the

    aminopenicillins, these agents are susceptible to

    inactivation by beta-lactamases.

    Chiefly used to treat serious infections caused by G-ve

    microorganisms, particular P.aeruginosa

    44

  • 8/3/2019 Antibiotic Module

    45/49

  • 8/3/2019 Antibiotic Module

    46/49

    Penicillin-beta-lactamase inhibitor

    combination

    Combination drugs:

    Ampicillin + Sulbactam = Unasyn

    Amoxicillin + Clavulanic acid = Augmentin

  • 8/3/2019 Antibiotic Module

    47/49

    Penicillins: Therapeutic uses

    1. Meningitis,

    2. Bacterial pneumonia,

    3. Streptococcal infections,

    4. Syphilis,

    5. Prophylactic against:

    Gonococcal infection Recurrence of rheumatic fever.

  • 8/3/2019 Antibiotic Module

    48/49

    Penicillins: side effects

    Hypersensitivity

    skin rashes, fever, and anaphylactic shock.

    Cross-reactivity exists among all penicillins andeven otherb-lactams

    Because the penicillins(especially broad

    spectrum penicillins) may alter gut flora,antibiotic-associated diarrhea can occur, as

    well as selecting out resistant bacteria in the

    colon (superinfections).48

  • 8/3/2019 Antibiotic Module

    49/49